Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis

BACKGROUND: Primary breast cancer (BC) has shown a higher immune infiltration than the metastatic disease, justifying the optimal scenario for immunotherapy. Recently, neoadjuvant chemotherapy (NAC) combined with immune checkpoint inhibitors has demonstrated a gain in pathological complete responses...

Descripción completa

Detalles Bibliográficos
Autores principales: Santisteban, Marta, Solans, Belén Pérez, Hato, Laura, Urrizola, Amaia, Mejías, Luis Daniel, Salgado, Esteban, Sánchez-Bayona, Rodrigo, Toledo, Estefanía, Rodríguez-Spiteri, Natalia, Olartecoechea, Begoña, Idoate, Miguel Angel, López-Díaz de Cerio, Ascensión, Inogés, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721381/
https://www.ncbi.nlm.nih.gov/pubmed/34987618
http://dx.doi.org/10.1177/17588359211064653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721381/
https://www.ncbi.nlm.nih.gov/pubmed/34987618
http://dx.doi.org/10.1177/17588359211064653

Ejemplares similares